Related Experiment Videos
Dehydration behavior and structural characterization of the GW275919X monohydrate
1Strategic Technologies, GlaxoSmithKline Inc., Five Moore Drive, Research Triangle Park, NC 27709, USA. jim.zhu@frx.com
International Journal of Pharmaceutics
|March 28, 2006
Summary
The muscle relaxant GW275919X monohydrate undergoes dehydration, revealing its crystal structure and physical stability. Understanding its solid-state transformation is crucial for effective lower back pain treatment.
Area of Science:
- Solid-state chemistry
- Crystallography
- Pharmaceutical sciences
Background:
- GW275919X is a central muscle relaxant used for lower back pain.
- The drug exists as a monohydrate, necessitating an understanding of its solid-state properties.
Purpose of the Study:
- To investigate the solid-state dehydration behavior and crystal structure of GW275919X monohydrate.
- To determine the physical stability of the drug based on its solid-state transformations.
Main Methods:
- Thermal analysis (DSC/TGA) and hot-stage powder X-ray diffraction (PXRD) were employed.
- Single crystal X-ray diffraction was used for crystal structure determination.
- Molecular modeling (Cerius²) and BFDH calculations were utilized for visualization and morphology prediction.
Main Results:
- The crystal structure was determined to be monoclinic, space group P21/c, with specific lattice parameters.
- Water molecules are integral to the crystal structure through hydrogen bonding, contributing to its coherence.
- Morphology predictions indicated the longest dimension aligns with the b-direction, matching experimental needle axis observations.
Conclusions:
- The study elucidates the dehydration process and crystal structure of GW275919X monohydrate.
- Hydrogen bonding plays a key role in the stability of the hydrate crystal structure.
- Understanding these solid-state characteristics is vital for the physical stability and formulation of GW275919X.